glp 1 agonist meds Comparing Ozempic, Wegovy and Other GLP-1 Drugs ascendis pharma glp-1 receptor agonist

Mechanism of Action GLP-1 agonists exert their effects through multiple mechanisms, all of which contribute to their therapeutic benefits

These medications have undergone extensive clinical trials to evaluate their efficacy and safety in managing type 2 diabetes and, more recently, their potential for weight loss

Market Outlook and Strategic Insights The obesity and weight loss treatment landscape will undergo substantial transformation in the coming years

Conclusions The present review goes so far as to suggest that GLP-1 medicines represent a watershed moment in treating chronic diseases, with their therapeutic reach extending well beyond their creators' expectations

Clinical Trial Results STEP trials (Semaglutide Treatment Effect in People with obesity): Average weight loss of ~15% of total body weight